Curriculum vitae for mark cushman - Purdue College of Pharmacy ...

Mark Cushman
75. "From the Hood to the Hospital: How and Indenoisoquinoline Accident Turned into an
Anticancer Drug," Symposium Recognizing Professor Yusuf Abul-Hajj, University of
Minnesota, June 23, 2010.
76. "The 13 th Webster-Sibilsky Lecture in Medicinal Chemistry in Recognition of
Contributions to the Field of Medicinal Chemistry," University of Illinois at Chicago,
March 16, 2012.
Research Grants and Contracts:
1. $133,049, National Institutes of Health, CA-19204, "New Benzophenanthridine and
Protoberberine Syntheses," 1976-1979.
2. $6,650, American Cancer Society and the Indiana Elks, "Synthesis of Antileukemic
Benzophenanthridine and Protoberberine Alkaloids," 1975-1977.
3. $8,940, David Ross Grant, "New Riboflavin Antimetabolites," 1978-1980.
4. $192,743, National Institutes of Health, CA-19204, "New Alkaloid Syntheses," 1979-
1982.
5. $157,177, National Institutes of Health, CA-27517, "Synthesis of Streptonigrin," 1980-
1983.
6. $13,200, David Ross Grant, "The Synthesis and Evaluation of Fluorinated
Ribityllumazines as Potential Inhibitors of Riboflavin Synthase," 1982-1984.
7. DM 57,528, Fulbright Commission, "Synthesis and Biochemical Evaluation of Potential
Riboflavin Synthase Inhibitors," 1983-1984.
8. $238,898, National Institutes of Health, GM-30932, "New Alkaloid Syntheses," 1982-
1985.
9. $7600, Bioanalytical Systems, "New Alkaloid Syntheses," 1985-1986.
10. $13,200, David Ross Grant, "Design, Synthesis and Biological Evaluation of Potential
Lumazine Synthase and Riboflavin Synthase Inhibitors,"1986-1988.
11. $729,057, National Institutes of Health, "Synthesis of Congeners and Prodrugs," NO1-
CM-67699, 1986-1991.
12. $1,568,000, National Institutes of Health, AI-24289 "National Cooperative Drug
Discovery Group for the Treatment of AIDS - Synthetic Approach, Co-PI with Dr. S.R.
Byrn (PI) and Dr. H.L. Weith (Co-PI), 1987-1990.
13. $252,484, National Institutes of Health, CA47476, "Protein-tyrosine Kinase Inhibitors as
Anticancer Agents," 1988-199l.
14. $386,797, National Institutes of Health, AI-25712 "Anti-HIV (AIDS) Agents Targeted to
the RNA Template", Co-PI with Dr. S.R. Byrn (PI) and Dr. H.L. Weith (Co-PI), 1988-
1990.
15. $496,992, National Institutes of Health, NO1-CM-87268, "Synthesis of Congeners and
Prodrugs of Anti-AIDS Compounds," 1988-1991.
16. $15,960, David Ross Grant, "Synthesis of Phosphotyrosine-containing Peptides as
Potential Inhibitors of Protein-tyrosine Kinases", 1990-1992.
17. $597,420, National Institutes of Health, NO1-CM-17513, "Synthesis of Congeners and
Prodrugs of Anti-AIDS Compounds", 1991-1994.
18. $1,136,933, National Institutes of Health, NO1-CM-17512, "Synthesis of Congeners and
Prodrugs," 1991-1996.
19. $19,800, Purdue Research Foundation Grant, "Design and Synthesis of Protein-Tyrosine
Kinase Inhibitors Based on Natural Product Templates," 1992-1994.
43